MicroTransponder has reported the results of a one-year follow-up study of its Vivistim Paired VNS System for chronic stroke recovery, revealing improvement in chronic stroke survivors with motor impairment. The Vivistim system, an implantable device, initially received FDA approval in 2021. The study findings, published in Stroke and announced by the company yesterday, validate Paired […]
MicroTransponder Inc.
MicroTransponder raises $65M for nerve stim tech
MicroTransponder announced today that it raised $65 million in a Series F financing round to support its Vivistim system. Vivistim, a vagus nerve stimulation (VNS) system, aims to help ischemic stroke survivors improve hand and arm function when paired with occupational or physical therapy. Paired VNS helps increase neuroplasticity, enabling stroke survivors to make gains […]
MicroTransponder Vivistim nerve stim tech delivers positive stroke outcomes
MicroTransponder recently announced positive real-world outcomes for its Vivistim vagus nerve stimulation (VNS) system. Data highlighted Vivistim’s impact when paired with occupational or physical therapy to help ischemic stroke survivors improve hand and arm function. The study demonstrated 2-3 times improved arm function compared to traditional stroke therapy alone. Dr. Ronald P. Benitez presented safety […]
MicroTransponder reports first commercial implantation of its stroke rehab neurostim system
MicroTransponder (Austin, Texas) recently announced the first commercial implantation of its Vivistim paired VNS system for chronic ischemic stroke rehabilitation. Dr. Charles Y. Liu, director of the University of Southern California Neurorestoration Center, and Dr. Jonathan J. Russin, director of the USC Neuro Revascularization Center, successfully placed the small Vivistim device under the skin of […]
FDA approves MicroTransponder’s stroke rehab neurostim system
The FDA announced today that it approved the MicroTransponder Vivistim paired VNS system for chronic ischemic stroke rehabilitation. MicroTransponder designed its Vivistim System as a first-of-its-kind, drug-free rehabilitation system for treating moderate to severe upper extremity motor deficits associated with chronic ischemic stroke using vagus nerve stimulation, according to an FDA news release. Vivistim electrically […]
Neurostimulation may help restore arm function years after stroke
Stroke survivors who received vagus nerve stimulation (VNS) combined with rehabilitation had better arm and hand function, according to the results of a new study. In the international, multi-center clinical trial, 53 participants with moderate to severe arm weakness nine months to 10 years post-stroke received rehabilitation paired with VNS. Fifty-five patients within the same […]
7 medtech stories we missed this week: June 2, 2017
From Implandata receiving CE Marking to Inolife eyeing up-listing, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. Dextera seeks expanded indications for MicroCutter 5/80 stapler Dextera Surgical announced in a June 1 press release that it has filed a 510(k) with the FDA for its MicroCutter 5/80 stapler. The […]
Neuravi closes $6.5M round for clot retrieval | Funding Roundup

Neuravi successfully completes Series A financing
Irish medical device company Neuravi Limited successfully completed a Series A financing round for $6.5 million (€5.2 million).